in bone. Even though only less than 1% of body calcium is in the extracellular space, maintaining the extracellular calcium concentration within a narrow range (8.5-10.5 mg/ dL) is very important for calcium homeostasis. Approximately 40% of plasma calcium is protein-bound and 10% of calcium is in a complex with anions like phosphate, citrate, and sulfate etc. Only half of plasma calcium is in its free form (ionized form, iCa 
Introduction
The maintenance of calcium homeostasis is very important because calcium is the main component of bony skeleton and serves as the intracellular and extracellular messenger in numerous essential cellular events such as neuronal network, immune response, muscle contraction, and hormone secretion. Total body calcium in the adult human is about 1-2 kg and 99% of total calcium exists in the fine regulation of calcium excretion 1) .
This review will focus on how the kidney works for calcium homeostasis on a molecular basis and discuss new players in the regulation of calcium excretion which were identified recently.
Overview of renal Ca 2+ handling
About 50% of plasma calcium (ionized and complexed form; ultrafilterable fraction, excluding the protein bound form) is freely filtered through the renal glomerulus, and 99% of the filtered calcium is actually reabsorbed along renal tubules ( Table 1 . Diuretics like thiazide and furosemide also alter calcium absorption in the renal tubules; thiazide promotes calcium reabsorption and furosemide inhibits it 4, 5) . Plasma calcium itself also controls renal calcium absorption through altered PTH secretion as well as via binding to the calcium sensing receptor (CaSR) channel in the PT 6) . There is no evidence that Ca 2+ reabsorption occurs in the thin descending and ascending limb.
In the TAL, 15% of filtered calcium is absorbed, and the passive absorption through paracellular space is known as the main mechanism ( Fig. 1) . Paracellin-1 (claudin-16) is exclusively expressed in the tight junction of TAL and has been known as the important magnesium channel in the TAL 6) . Paracellin-1 mutation caused hypercalciuria and nephrocalcinosis in addition to hypomagnesemia 2) . This finding supports that paracellin-1 is not only the main Mg 2+ channel, but also works as the paracellular Ca 2+ channel in the TAL. There are some evidences that active transport occurs in the TAL, but no specific channel has yet been identified 1) . The CaSR is a member of G protein-coupled receptors and suppresses PTH secretion by sensing high plasma Ca 2+ level in the parathyroid glands 7) . In the kidney, . BSC1, bumetanide sensitive channel; ROMK, renal outer medullary potassium channel; ClCNKB, chloride channel Kb. 
Renal calcium transport proteins
The important renal calcium transport proteins are exclusively expressed in the DCT and CNT. The characteristics and regulation of calcium transporting proteins will be discussed as follows.
TRPV5 and TRPV6
Transient receptor potential (TRP) channel is a super- (PCa/PNa >100) 9) . TRPV5 and TRPV6 have the highest sequence homology (~730 amino acids, amino-terminal ankyrin repeats, TM5 and TM6 each forming the pore-region composed with tetramer, on human chromosome 7q34-35) (Fig. 3a) . TRPV5 is exclusively expressed in the DCT and CNT in the kidney 10) (Fig. 3b) . On the contrary, TRPV6 is more ubiquitously distributed, especially in the intestine, and also found from the DCT to the CD in the kidney 11) (Fig. 3b) . Both TRPV5 and TRPV6
are located in the apical plasma membrane of the tubular epithelium, and serve as the entrance of Ca 2+ from the lumen into the cytoplasm. TRPV5 knockout mice exhibited severe hypercalciuria (more than 6 times of wild type mouse) and low bone densities, but without hypocalcemia due to the compensatory elevation of activated vitamin D, clearly demonstrating that TRPV5 plays a crucial role in renal calcium reabsorption 12) . TRPV6 knockout mice also showed significant hypercalciuria and bone disease 13) .
Even though TRPV5 and TRPV6 knockout mice showed congenital hypercalciuria, the mutation of the proteins has not been found in the human. . The promoter region of TRPV5 gene . (b) TRPV5 is exclusively expressed in the apical membrane of the DCT and CNT cells (especially DCT-2). TRPV6 is co-localized with TRPV5, but also observed in the collecting duct (the lower panel). Na + /Cl -cotransporter (NCC) is the DCT and CNT marker 10, 11) . ECaC, epithelial calcilulm channel 1 (TRPV5); NCX, Na Recently, several studies were performed to document whether these drugs affect renal calcium transport proteins.
Furosemide has been used for the treatment of hypercalcemia for many years because it was well known to reduce However, the same authors reported later that TRPV5 mRNA was not changed by thiazide 14) . They also suggested that thiazide-induced hypocalciuria was caused by the enhanced passive Ca 2+ transport in the proximal tubule rather than by the action of Ca 2+ transport proteins in the DCT using TRPV5 knockout mice 14) . On the other hand,
Lee et al. reported that the effect of thiazide on calcium transport proteins depended upon the volume status;
thiazide increased the expression of TRPV5 and calbindin-D28K only when there was no volume contraction 15) .
According to Jang et al., TRPV5 and calbindin-D28K were upregulated by thiazide in hypercalciuric rats 16) . Therefore, the mechanism of hypocalciuria induced by thiazide needs to be clarified in the future. It has been demonstrated that the channel activation of TRPV5 and TRPV6 require other associated proteins like S100A10 (p11 or annexin 2 light chain)/annexin 2, Rab11b, 80K-H, and NHERF 9) . In addition, klotho is also known to be involved in the trafficking of TRPV5, which will be discussed in detail later. The coordinated regulation of the abundance, trafficking, and channel activity of TRPV5/6 by these factors can maintain balanced renal Ca 2+ excretion.
Calbindin-D 28K
Calbindin is a cytosolic calcium-binding protein which is involved in transcellular calcium diffusion and buffers cytosolic Ca 2+ to maintain a very low physiologic intracellular Ca 2+ concentration. Two isoforms of calbindin exist;
calbindin-D28K which is exclusively expressed in the mammalian kidney and calbindin-D9K primarily in the inte- , but also as the dynamic regulatory factor of TRPV5 channel activity 17) .
NCX1 and PMCA1b
NCX1 and PMCA1b are expressed in the basolateral membrane of the DCT and CNT, and act as the main exit of absorbed Ca 2+ to the blood compartment (Fig. 3b) reabsorption, an active transport mechanism is necessary in these segments. NCX1 is a secondary active transporter generated by the action Na . PMCA1b is a primary active calcium pump and most of its activity is seen in the DCT 1) . Both NCX1 and PMCA1b are regulated by PTH, calcitonin, and 1,25(OH)2D3 in the distal nephron (Fig. 4) . named it as it is now, because it was originally known as an aging-suppressor gene 18) . Klotho mutant mice resembled human aging; a short lifespan, infertility, arteriosclerosis, skin atrophy, uncoordinated movement, osteoporosis, emphysema, etc. 18) . Klotho protein belongs to type 1 membrane protein (single transmembrane domain, 1,014 amino acids,~130 kDa) and has an extracellular domain with similarity to -glycosidase, the enzyme in β -volved in the digestion of sugar moieties of substrates.
New players of renal calcium handling
Although klotho is a membrane protein, it is also abundant in the cytoplasm and the cleaved extracellular domain is secreted into blood, cerebrospinal fluid and urine 19) . Fig. 4 . The summary of the distribution of major renal calcium transport proteins. G, glomerulus; PCT, proximal convoluted tubule; PST, proximal straight tubule; S1, segment 1; S2, segment 2; S3, segment 3; DTL, descending thin limb; ATL, ascending thin limb; mTAL, medullary thick ascending limb; cTAL, cortical thick ascending limb; MD, macula densa; DCT, distal convoluted tubule; CNT, connecting tubule; ICD, initial collecting duct; CCD cortical collecting duct; OMCD, outer medullary collecting duct; IMCD, inner medullary collecting duct; TRPV, transient receptor potential vallinoid; PMCA1b, plasma membrane Ca Klotho has been suggested to play an important role in the kidney because it is highly expressed in the kidney and klotho knockout mice showed severe hyperphosphatemia associated with increased 1,25(OH)2D3 levels 18) .
-Klotho ( -Kl) is highly co-expressed with TRPV5, α α NCX1, and calbindin-D28K in the kidney 20) (Fig. 5a) .
-α KI was required for the rapid recruitment of Na
ATPase to the cell surface in response to high extracellular Ca 2+ concentration 19) . This activation of Na . This hydrolyzed TRPV5
was entrapped in the plasma membranes and then caused increase in Ca 2+ reabsorption 20) (Fig. 5b) . In addition, klotho has interactions with FGF23 and contributes to renal Ca 2+ handling. Klotho binds to canonical FGF receptor (FGFR) and converts it into a specific receptor for FGF23, and then -Kl in combination with FGF23 negatively re α -gulates vitamin D production in the kidney 21, 22) . 23, 24) . . Klotho converts canonical FGFR to specific FGF23 receptor to make it possible for the FGF23:klotho complex to bind to the receptor, and then this complex regulates the activation of vitamin D (Fig. 6b) . However, the exact mechanism how FGF23:klotho regulates renal phosphate excretion is still unknown. It is still unknown how the risk factor for higher mortality among dialysis patients 26) .
FGF23 also plays some roles in the parathyroid glands and other organs like the choroid plexus, pituitary gland, and bone. However, further studies are needed to clarify the roles and the mechanisms.
Conclusion
The kidney has been known as the central organ for calcium homeostasis through fine regulation of renal calcium excretion. For the past decade, there has been big progress in the understanding of the roles of the kidney in calcium homeostasis. The identification of calcium transport proteins and the molecular approach to the regulatory mechanisms achieved a major contribution to this progress. TRPV5, TRPV6, calbindin-D28K, NCX1, and 
